Nicotine exposure induces the proliferation of oral cancer cells through the α7 subunit of the nicotinic acetylcholine receptor.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
05 02 2019
Historique:
received: 19 12 2018
accepted: 21 12 2018
pubmed: 2 1 2019
medline: 29 10 2019
entrez: 2 1 2019
Statut: ppublish

Résumé

Oral cancer and smoking are closely related, because the oral cavity, which is the route of ingestion of tobacco smoke, is in direct contact with the oral mucosa. Nicotine, one of the components of tobacco, can diffuse rapidly to the central nervous system and is responsible for tobacco addiction. Nicotine is present in high concentrations in the bloodstream of smokers; while the addictive effects of this alkaloid have extensively been studied, its effect on tumorigenesis is not clear yet. Therefore, in this study, we examined the effect of nicotine on cell proliferation and the signaling pathways it activates. The human oral squamous cell carcinoma cell line HSC-2 was used as a model system. We demonstrated the correlation between nicotine and epidermal growth factor receptor (EGFR) signaling. Nicotine treatment induced HSC-2 cell proliferation and migration and the phosphorylation of EGFR. Furthermore, nicotine treatment activated the EGFR downstream effectors phosphatidylinositol-3 kinase/AKT and p44/42 mitogen-activated protein kinases (ERK), which, in turn, promoted cell proliferation. Overall, our study suggests that nicotine promotes cell growth and migration through epidermal growth factor (EGF) signaling and plays an important role in oral cancer progression.

Identifiants

pubmed: 30598264
pii: S0006-291X(18)32823-7
doi: 10.1016/j.bbrc.2018.12.154
pii:
doi:

Substances chimiques

alpha7 Nicotinic Acetylcholine Receptor 0
Nicotine 6M3C89ZY6R
ErbB Receptors EC 2.7.10.1
Proto-Oncogene Proteins c-akt EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

514-520

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Takashi Nishioka (T)

Division of Oral Diagnosis, Tohoku University Graduate School of Dentistry, Sendai, Japan. Electronic address: tnishiok@tohoku.ac.jp.

Hiroyuki Tada (H)

Division of Oral Immunology, Tohoku University Graduate School of Dentistry, Sendai, Japan.

Soichiro Ibaragi (S)

Department of Oral and Maxillofacial Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Changyan Chen (C)

Center for Drug Discovery, Northeastern University, Boston, MA, USA.

Takashi Sasano (T)

Division of Oral Diagnosis, Tohoku University Graduate School of Dentistry, Sendai, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH